|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marmol I, Sanchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18:1972017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng L, Poon RT and Pang R: Biomarkers for
predicting future metastasis of human gastrointestinal tumors. Cell
Mol Life Sci. 70:3631–3656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue B: Biology of the extracellular
matrix: An overview. J Glaucoma. 23 (Suppl 1):S20–S23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitadai Y, Sasaki T, Kuwai T, Nakamura T,
Bucana CD and Fidler IJ: Targeting the expression of
platelet-derived growth factor receptor by reactive stroma inhibits
growth and metastasis of human colon carcinoma. Am J Pathol.
169:2054–2065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Zhang W, Sun X, Lin Y and Chen W:
Cancer-associated fibroblasts induce epithelial-mesenchymal
transition through secreted cytokines in endometrial cancer cells.
Oncol Lett. 15:5694–5702. 2018.PubMed/NCBI
|
|
11
|
Shinagawa K, Kitadai Y, Tanaka M, Sumida
T, Kodama M, Higashi Y, Tanaka S, Yasui W and Chayama K:
Mesenchymal stem cells enhance growth and metastasis of colon
cancer. Int J Cancer. 127:2323–2333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takigawa H, Kitadai Y, Shinagawa K, Yuge
R, Higashi Y, Tanaka S, Yasui W and Chayama K: Mesenchymal stem
cells induce epithelial to mesenchymal transition in colon cancer
cells through direct cell-to-cell contact. Neoplasia. 19:429–438.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bradshaw AD and Sage EH: SPARC, a
matricellular protein that functions in cellular differentiation
and tissue response to injury. J Clin Investig. 107:1049–1054.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schultz C, Lemke N, Ge S, Golembieski WA
and Rempel SA: Secreted protein acidic and rich in cysteine
promotes glioma invasion and delays tumor growth in vivo. Cancer
Res. 62:6270–6277. 2002.PubMed/NCBI
|
|
16
|
Massi D, Franchi A, Borgognoni L, Reali UM
and Santucci M: Osteonectin expression correlates with clinical
outcome in thin cutaneous malignant melanomas. Hum Pathol.
30:339–344. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamanaka M, Kanda K, Li NC, Fukumori T,
Oka N, Kanayama HO and Kagawa S: Analysis of the gene expression of
SPARC and its prognostic value for bladder cancer. J Urol.
166:2495–2499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang E, Kang HJ, Koh KH, Rhee H, Kim NK
and Kim H: Frequent inactivation of SPARC by promoter
hypermethylation in colon cancers. Int J Cancer. 121:567–575. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheetham S, Tang MJ, Mesak F, Kennecke H,
Owen D and Tai IT: SPARC promoter hypermethylation in colorectal
cancers can be reversed by 5-Aza-2′ deoxycytidine to increase SPARC
expression and improve therapy response. Br J Cancer. 98:1810–1819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ministry of Education, Culture, Sports,
Science and Technology, Ministry of Health, Labour and Welfare,
Ministry of Economy, Trade and Industry, . Ethics Guidelines for
Human Genome/Gene Analysis Research. https://www.lifescience.mext.go.jp/files/pdf/40_213.pdf
|
|
21
|
Morikawa K, Walker SM, Nakajima M, Pathak
S, Jessup JM and Fidler IJ: Influence of organ environment on the
growth, selection, and metastasis of human colon carcinoma cells in
nude mice. Cancer Res. 48:6863–6871. 1988.PubMed/NCBI
|
|
22
|
Santa María L, Rojas CV and Minguell JJ:
Signals from damaged but not undamaged skeletal muscle induce
myogenic differentiation of rat bone-marrow-derived mesenchymal
stem cells. Exp Cell Res. 300:418–426. 2004. View Article : Google Scholar
|
|
23
|
Ishii M, Koike C, Igarashi A, Yamanaka K,
Pan H, Higashi Y, Kawaguchi H, Sugiyama M, Kamata N, Iwata T, et
al: Molecular markers distinguish bone marrow mesenchymal stem
cells from fibroblasts. Biochem Biophys Res Commun. 332:297–303.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsutsumi S, Shimazu A, Miyazaki K, Pan H,
Koike C, Yoshida E, Takagishi K and Kato Y: Retention of
multilineage differentiation potential of mesenchymal cells during
proliferation in response to FGF. Biochem Biophys Res Commun.
288:413–419. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shinagawa K, Kitadai Y, Tanaka M, Sumida
T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W and
Chayama K: Stroma-directed imatinib therapy impairs the
tumor-promoting effect of bone marrow-derived mesenchymal stem
cells in an orthotopic transplantation model of colon cancer. Int J
Cancer. 132:813–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawai S, Takagi Y, Kaneko S and Kurosawa
T: Effect of three types of mixed anesthetic agents alternate to
ketamine in mice. Exp Anim. 60:481–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chin D, Boyle GM, Williams RM, Ferguson K,
Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG and Coman
WB: Novel markers for poor prognosis in head and neck cancer. Int J
Cancer. 113:789–797. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han W, Cao F, Chen MB, Lu RZ, Wang HB, Yu
M, Shi CT and Ding HZ: Prognostic value of SPARC in patients with
pancreatic cancer: A systematic review and meta-analysis. PLoS One.
11:e01458032016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu C, Wang X, Long T, Wang X, Zhong Y, Ma
Y, Hu Z and Li Z: FSTL1 interacts with VIM and promotes colorectal
cancer metastasis via activating the focal adhesion signalling
pathway. Cell Death Dis. 9:6542018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sipos B, Hahn D, Carceller A, Piulats J,
Hedderich J, Kalthoff H, Goodman SL, Kosmahl M and Klöppel G:
Immunohistochemical screening for beta6-integrin subunit expression
in adenocarcinomas using a novel monoclonal antibody reveals strong
up-regulation in pancreatic ductal adenocarcinomas in vivo and in
vitro. Histopathology. 45:226–236. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Langmead B and Salzberg SL: Fast
gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li B and Dewey CN: RSEM: Accurate
transcript quantification from RNA-Seq data with or without a
reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The genome analysis toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen S, Park JW, Lu ZX, Lin L, Henry MD,
Wu YN, Zhou Q and Xing Y: rMATS: Robust and flexible detection of
differential alternative splicing from replicate RNA-Seq data. Proc
Natl Acad Sci USA. 111:E5593–E5601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim JY, Jeong D, Ahn TS, Kim HJ, Park DS,
Park SY, Bae SB, Lee S, Lee SS, Lee MS, et al: Expression of
secreted protein acidic and rich in cysteine in the stroma of a
colorectal carcinoma is associated with patient prognosis. Ann
Coloproctol. 29:93–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang CS, Lin KH, Chen SL, Chan YF and
Hsueh S: Overexpression of SPARC gene in human gastric carcinoma
and its clinic-pathologic significance. Br J Cancer. 91:1924–1930.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guweidhi A, Kleeff J, Adwan H, Giese NA,
Wente MN, Giese T, Büchler MW, Berger MR and Friess H: Osteonectin
influences growth and invasion of pancreatic cancer cells. Ann
Surg. 242:224–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Porte H, Chastre E, Prevot S, Nordlinger
B, Empereur S, Basset P, Chambon P and Gespach C: Neoplastic
progression of human colorectal cancer is associated with
overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J
Cancer. 64:70–75. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang JF, Wang HK, Xiao H, Li N, Cheng CX,
Zhao YZ, Ma YB, Gao JZ, Bai RB and Zheng HX: Relationship and
prognostic significance of SPARC and VEGF protein expression in
colon cancer. J Exp Clin Cancer Res. 29:712010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yan Q and Sage EH: SPARC, a matricellular
glycoprotein with important biological functions. J Histochem
Cytochem. 47:1495–1506. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng J and Tang L: SPARC in tumor
pathophysiology and as a potential therapeutic target. Curr Pharm
Des. 20:6182–6190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sharma S, Xing F, Liu Y, Wu K, Said N,
Pochampally R, Shiozawa Y, Lin HK, Balaji KC and Watabe K: Secreted
protein acidic and rich in cysteine (SPARC) mediates metastatic
dormancy of prostate cancer in bone. J Biol Chem. 291:19351–19363.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ordonez JL, Paraoan L, Hiscott P, Gray D,
García-Fiñana M, Grierson I and Damato B: Differential expression
of angioregulatory matricellular proteins in posterior uveal
melanoma. Melanoma Res. 15:495–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takigawa H, Kitadai Y, Shinagawa K, Yuge
R, Higashi Y, Tanaka S, Yasui W and Chayama K: Multikinase
inhibitor regorafenib inhibits the growth and metastasis of colon
cancer with abundant stroma. Cancer Sci. 107:601–608. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Boneschansker L, Nakayama H, Eisenga M,
Wedel J, Klagsbrun M, Irimia D and Briscoe DM: Netrin-1 Augments
chemokinesis in CD4+ T cells in vitro and elicits a
proinflammatory response in vivo. J Immunol. 197:1389–1398. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun W, Feng J, Yi Q, Xu X, Chen Y and Tang
L: SPARC acts as a mediator of TGF-β1 in promoting
epithelial-to-mesenchymal transition in A549 and H1299 lung cancer
cells. Biofactors. 44:453–464. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fenouille N, Tichet M, Dufies M, Pottier
A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari
A, et al: The epithelial-mesenchymal transition (EMT) regulatory
factor SLUG (SNAI2) is a downstream target of SPARC and AKT in
promoting melanoma cell invasion. PLoS One. 7:e403782012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen J, Ji T, Wu D, Jiang S, Zhao J, Lin H
and Cai X: Human mesenchymal stem cells promote tumor growth via
MAPK pathway and metastasis by epithelial mesenchymal transition
and integrin alpha5 in hepatocellular carcinoma. Cell Death Dis.
10:4252019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen L, Guo P, He Y, Chen Z, Chen L, Luo
Y, Qi L, Liu Y, Wu Q, Cui Y, et al: HCC-derived exosomes elicit HCC
progression and recurrence by epithelial-mesenchymal transition
through MAPK/ERK signalling pathway. Cell Death Dis. 9:5132018.
View Article : Google Scholar : PubMed/NCBI
|
